Alok Sharma

Director, Renal Pathology & Electron Microscopy and Head (R&D) at Dr Lal PathLabs Ltd. Views are my own...

[Indian Society of Renal& Transplantation Pathology @IndianRenal]

Annual meeting of ISRTP, the ISRTPCON 2026 will be held at St Johns Medical College, Bengaluru from 12-14th November 2026.
For details and registration, please visit https://t.co/HbKjmJSkzz

[Alok Sharma @draalok]

@SethiRenalPath @umnmedschool Congratulations and best wishes 💐

[Vincent Rajkumar @VincentRK]

Just out! New IMS/ IMWG Definition of High Risk Myeloma.
@JCO_ASCO #IMWG25

@Myeloma_Society @IMFmyeloma @NikhilMunshiMD @mvmateos @SagarLonialMD @szusmani @NoopurRajeMD

[Sanjeev Sethi @SethiRenalPath]

Sorry I accidentally deleted the original post while trying to answer some questions.

I’m still a novice with X 😁

Take home message: small ~3% of PLA2R negative MN cases by routine IF are PLA2R positive by LMD/MS.

https://t.co/070fDPcLbM

[Dr Geetika Singh @DrGeetikaSingh1]

Join us as we discuss the cutting edge in precision diagnosis in amyloidosis and kidney disease @isn_india @IndianRenal @aiims_newdelhi @lalpathlabs

[Indian Society of Renal& Transplantation Pathology @IndianRenal]

Announcing the 18th annual meeting of ISRTP at Ahmedabad! Register today to be a part of this academic extravaganza!
https://t.co/09gvlVZne1

[Smita Divyaveer, MD, DM Nephrology @DivyaveerSSNeph]

🆕📃👀 ANCA negative pauci immune GN ▶️A large series
⬆️ Chronicity and advanced diseased at diagnosis
🫘 limited
⬇️ Relapses, yet poorer prognosis due to advanced disease
@ISNkidneycare
@ISNeducation @KIReports #Nephtwitter #NephX #Nephrology #NephEd #Medtwitter #MedX

[Tobias B. Huber @Tobias_B_Huber]

Key insight: Anti-nephrin podocytopathy is a low-titer autoantibody disease. Enrichment steps to capture circulating antibodies facilitate the robust quantification of disease activity. @NicolaMTomas @hengel_f @AstridWeins

[Grace Choung, MD 박영이 @grace_choung]

Diagnostic Immunostaining of Renal Biopsies: An Overview of Markers for Glomerular Diseases https://t.co/6ecYRvWtXP
@draalok #GlomerularDiseases

[Renal Pathology Society @Renalpathsoc]

For more information on how to join, CLICK LINK: https://t.co/bRyZF7p7Dc
@GlomCon @AnilaKurien

[Indian Society of Renal& Transplantation Pathology @IndianRenal]

Announcing the 2nd edition of annual ISRTP post graduate outreach program (iPROP2). Great opportunity for Pathology and Nephrology fellows and consultants to brush up your skills https://t.co/09gvlVZne1
#iprop #renalpathology #nephrology

[Prof Dr. rer. nat. Nicole Endlich @EndlichNicole]

MAGI2, is a new biomarker for glomerulopathies! 🌟 This slit diaphragm protein is key to nephrin 🐙localization and causes effacement shown with our rapid zebrafish model. 🐟🔬
With MAGI2, we can distinguish primary from secondary FSGS!
As shown in our manuscript uploaded at bioRxiv, even FSD (filtration slit density) measured by PEMP at @NIPOKA_Podocyte alone offers a clear differentiation between primary and secondary FSGS, marking an amazing step for kidney biopsy analysis and patient care!
This discovery is a result of extraordinary collaboration within the STOP-FSGS project, funded by BMBF, bringing together world-class research teams:
🇩🇪 @Tobias_B_Huber 's lab
🇩🇪 UKE Pathology
🇫🇷 Christos Chatziantoniou's lab
🇮🇹 @GianniCapasso4 's lab
🇩🇪 Thomas Benzing ’s lab
🇩🇪 Uwe Völker's lab
🇩🇪 @NIPOKA_Podocyte GmbH
🇩🇪 and my fantastic team at the @UMGreifswald

https://t.co/9embf4mr5O

A heartfelt thank you to all involved in this international effort !🌍💪🔬🙏

[Indian Society of Renal& Transplantation Pathology @IndianRenal]

We have migrated to a brand new website! Please access the new website of Indian Society of Renal & Transplantation Pathology at https://t.co/09gvlVZne1 for recent updates about our activities, academic content and much more.#newwebsite #renalpathology #PathTwitter

[Sanjeev Sethi @SethiRenalPath]

This is difficult & rare.
Suspicion is key.

LM-large glomeruli, appear hypercellular, but a closer look & you see foam cells.

Stain for CD68 & glomerular capillaries light up & are filled with CD68+ macrophages.

IF/EM essentially negative.

Dx: Histiocytic glomerulopathy
1/3

[NDT @NDTsocial]

Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation

https://t.co/Ihj59qVsjF

Dd-cfDNA-guided biopsy in KTR with prevalent dnDSA can reduce the time to AMR diagnosis and expedite therapy initiation

[M Abdul Qader🇧🇩 @md_abdulqader83]

Viral Nephropathies: Core Curriculum 2024

https://t.co/Uo5UUHjNCw

[Tiffany Caza @Tiff_Caza]

Monotypic fibrillary glomerulonephritis is not a MGRS in the vast majority of cases.
In cases with monotypic fibrillary - do IgG subclasses, do par IF, and check SPEP/UPEP for evaluation of true clonality.
Insights from @VBijol and @MayoClinicPath at @GlomCon

[NEJM @NEJM]

Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. https://t.co/FzWH6RAY28

#KidneyWk

[Dr Geetika Singh @DrGeetikaSingh1]

AIIMS, Delhi & Mayo Clinic are getting together to talk about the latest advances in Kidney diseases and Transplant. An interesting program with a look at the latest in Complement, Genetics, Stem cell therapy with a plethora of real life cases. Join us @isn_india @IndianRenal

[Sanjeev Sethi @SethiRenalPath]

Membranous Nephropathy (MN): It is becoming increasingly important to identify the antigen in MN.

Each MN-antigen has distinctive clinical, pathology, and prognostic implications.

Mass spectrometry is the method of choice for identifying MN antigens.

https://t.co/xp3vDOOwET